Does OLMESARTAN Cause Hypomagnesaemia? 24 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Hypomagnesaemia have been filed in association with OLMESARTAN. This represents 1.1% of all adverse event reports for OLMESARTAN.
24
Reports of Hypomagnesaemia with OLMESARTAN
1.1%
of all OLMESARTAN reports
0
Deaths
22
Hospitalizations
How Dangerous Is Hypomagnesaemia From OLMESARTAN?
Of the 24 reports, 22 (91.7%) required hospitalization, and 3 (12.5%) were considered life-threatening.
Is Hypomagnesaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLMESARTAN. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does OLMESARTAN Cause?
Sprue-like enteropathy (391)
Diarrhoea (313)
Gastrointestinal disorder (276)
Acute kidney injury (209)
Weight decreased (197)
Hypotension (176)
Drug ineffective (131)
Dizziness (115)
Hypokalaemia (110)
Dyspnoea (106)
What Other Drugs Cause Hypomagnesaemia?
OMEPRAZOLE (1,766)
PANTOPRAZOLE (1,246)
PANITUMUMAB (611)
ESOMEPRAZOLE (591)
CARBOPLATIN (586)
LANSOPRAZOLE (504)
FUROSEMIDE (501)
FLUOROURACIL (477)
METFORMIN (415)
CISPLATIN (395)
Which OLMESARTAN Alternatives Have Lower Hypomagnesaemia Risk?
OLMESARTAN vs OLMESARTAN MEDOXOMIL
OLMESARTAN vs OLMETEC
OLMESARTAN vs OLODATEROL
OLMESARTAN vs OLODATEROL\TIOTROPIUM
OLMESARTAN vs OLOPATADINE